Cargando…
Repurposing Cationic Amphiphilic Drugs and Derivatives to Engage Lysosomal Cell Death in Cancer Treatment
A major confounding issue in the successful treatment of cancer is the existence of tumor cell populations that resist therapeutic agents and regimens. While tremendous effort has gone into understanding the biochemical mechanisms underlying resistance to each traditional and targeted therapeutic, a...
Autores principales: | Hu, Michelle, Carraway, Kermit L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793984/ https://www.ncbi.nlm.nih.gov/pubmed/33425762 http://dx.doi.org/10.3389/fonc.2020.605361 |
Ejemplares similares
-
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
por: Ellegaard, Anne-Marie, et al.
Publicado: (2016) -
The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies
por: Berg, Anastasia L., et al.
Publicado: (2022) -
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs
por: Bogaert, Bram, et al.
Publicado: (2022) -
Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021) -
A Cell-Permeant Amiloride Derivative Induces Caspase-Independent, AIF-Mediated Programmed Necrotic Death of Breast Cancer Cells
por: Leon, Leonardo J., et al.
Publicado: (2013)